References
I have decided to develop an open-ended post listing potentially relevant and interesting papers from the primary literature related to glioblastoma. These will primarily be intended to serve as reminders about ideas I'd like to learn more about when I have the opportunity to ask questions. In cases where I only have access to an abstract I have requested a pdf reprint from the corresponding author.
Adamson, C. et al. 2009. Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opinion on Investigational Drugs 8(18): 1061-1083. So far, I have only read the abstract, but this one looks like it might provide a good comprehensive overview of the current state of the science.
Heimberger, AB & Sampson, JH. 2009. The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients. Expert Opinion on Biological Therapy 9(8): 1087-1096. Seems like a potentially promising approach though I don't know if my little goblin had the requisite EGFR variant III.
Adamson, C. et al. 2009. Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opinion on Investigational Drugs 8(18): 1061-1083. So far, I have only read the abstract, but this one looks like it might provide a good comprehensive overview of the current state of the science.
Heimberger, AB & Sampson, JH. 2009. The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients. Expert Opinion on Biological Therapy 9(8): 1087-1096. Seems like a potentially promising approach though I don't know if my little goblin had the requisite EGFR variant III.
Labels: Cancer Biology

0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
Links to this post:
Create a Link
<< Home